Form 4: Firefly Neuroscience President and COO, David DeCaprio, Awarded Restricted Stock Units

David DeCaprio, President and COO of Firefly Neuroscience, was granted 131,976 restricted stock units (RSUs) as part of the company's 2024 Long-Term Incentive Plan.

Summary

• On April 18, 2025, David DeCaprio, the President and COO of Firefly Neuroscience, was granted 131,976 restricted stock units (RSUs).
• These RSUs were granted under the Issuer's 2024 Long-Term Incentive Plan.
• The grant serves as partial compensation for DeCaprio's service as President and COO.
• The RSUs will vest quarterly in twelve equal installments, starting on June 27, 2025.
• Vesting is contingent upon DeCaprio's continuous service with the company.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of RSUs is a standard practice and indicates confidence in the executive's continued contribution. It's a routine event, but positive for aligning interests.

Positives

• The grant of RSUs aligns the executive's interests with those of the shareholders, incentivizing continued service and performance.
• The vesting schedule encourages long-term commitment from the President and COO.

Risks

• The value of the RSUs is dependent on the future performance of Firefly Neuroscience's stock.
• If DeCaprio's service is terminated before all RSUs vest, he will forfeit the unvested portion.

Future Outlook

The grant of RSUs suggests an expectation of continued service and contribution from the President and COO to the company's future success.

Industry Context

Granting stock-based compensation is a common practice in the neuroscience and biotechnology industries to attract and retain key executives, aligning their interests with the long-term success of the company. This is similar to compensation packages offered by companies like Biogen or Amgen to their executive teams.

Comparison to Industry Standards

• Stock-based compensation is a standard practice in the biotech industry to incentivize executives.
• Companies like Biogen and Amgen use similar compensation structures to align executive interests with shareholder value.
• The vesting schedule of twelve quarterly installments is a typical approach to ensure long-term commitment.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns management's interests with the company's long-term success.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates

Keywords

Restricted Stock Units, RSUs, David DeCaprio, Firefly Neuroscience, Compensation, Incentive Plan, Vesting, President, COO